Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)

Advice

NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. This is because data on the use of the assays in primary care has not been received. The assays are already recommended for use in NICE's guideline on myeloma: diagnosis and management.

NICE will review the position if the company or any other stakeholder suggests the topic to NICE again.

ISBN: 978-1-4731-4510-8